Radiopharmaceuticals – How to Register in EU? (October 2019)

Author
Published on
Category

Radiopharmaceuticals are a specific type of medicinal products. When ready for use they contain one or more radionuclides (radio-isotopes). Radionuclides dissipate excess energy by spontaneously emitting radiation in the form of alpha, beta, positron and gamma rays. Radiopharmaceuticals make use of the radiation emitted by radioisotopes. They are used for therapeutic (destruction of diseased body cells) and diagnostic purposes (detection of radiation and transforming into images).

Is a radiopharmaceutical a human medicinal product and under what conditions does it require registration?

Explore more Whitepapers

Approaches to include drug substance quality information in a drug product application (June 2022)

How to select a cell line to produce a biosimilar (June 2021)

Combination products in the EU MDR (May 2021)

Valentyna Starodub
Founder and Chief Executive Officer
Valentyna Starodub

Let's Connect

Talk to an expert